Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX01 vs placebo in rheumatoid arthritis (MTX-IR)
CTR20171434Phase 3Completed
- Sponsor
- Henlius
- Start
- Aug 2018
- Modality
- IgG Antibodies → Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hlx01 in rheumatoid arthritis (RA), sponsored by Henlius. Started Aug 2018; status: completed.
02
Drugs
hlx01
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20171434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171434.